Upcoming events

Menu
Log in


Log in

September 2019 TEMPO Luncheon

  • September 10, 2019
  • 11:30 AM - 1:15 PM
  • The Madison Club, 5 E. Wilson St., Madison

Registration


Registration is closed
Join us on Tuesday, September 10 to hear Lynn Allen-Hoffmann present How a Research Question Became a Personal Mission. 

Please plan to meet at The Madison Club at 11:30 am for networking; lunch will be served at noon.  Please register by Wednesday, September 4.

Dr. Lynn Allen-Hoffmann has devoted her career to the study of human skin cell biology. A chance discovery in Lynn’s UW-Madison laboratory in the 1990’s showed that certain cells could be cultured in a way that mimicked human skin tissue. After discussions with a burn surgeon at UW Hospital, Lynn realized these cells had significant promise as a treatment for serious skin loss such as severe burns.

In 2000, Lynn founded Stratatech Corporation to develop and commercialize a burn care product based on these cells and in doing so, became the first woman at UW-Madison to start a biotechnology business. Lynn summed up her vision: “It would be a career dream come true to develop some kind of off-the-shelf product that would be available to doctors.”

In 2016, Stratatech was acquired by the U.K. based company Mallinkrodt. The company remains located in the University Research Park and recently moved into larger state of the art biomanufacturing space. Lynn’s dream is close to coming true and her company has served as a model for other small high-tech businesses in the Midwest.

SPEAKER BIOGRAPHY: Dr. Allen-Hoffmann is internationally recognized for her innovative research and clinical development of human skin replacements including the world’s first genetically-enhanced human skin replacements.
 
She has received numerous state and national awards has contributed to numerous peer-reviewed publications and patents and is the first woman at UW-Madison to start a biotechnology company.  Dr. Allen-Hoffmann has been the Principal Investigator on two Biomedical Advanced Research and Development governmental contracts totaling over $250 million.  Her work has most recently been recognized by a 2016 Tibbitts Award presented in Washington D.C. and she was the winner of the 2017 Hector F. DeLuca Scientific Achievement Award.

Dr. Allen-Hoffmann is a tenured Professor in the Departments of Pathology and Laboratory Medicine and Surgery at the UW School of Medicine and Public Health. She received a bachelor’s degree from the University of Illinois and a Ph.D. from Cornell University. Dr. Allen-Hoffmann was a Damon-Runyon Walter-Winchell Postdoctoral Fellow at the Dana-Farber Cancer Institute at Harvard Medical School.
Powered by Wild Apricot Membership Software